Item 1.01 Entry into a Material Definitive
Agreement.
On May 25, 2022 (the “Issue Date”),
Home Bistro, Inc., a Nevada corporation (the “Company”), entered into those certain Securities Purchase Agreements
dated as of May 24, 2021 (the “SPAs”), by and between the Company and each of GS Capital Partners, LLC, a Nevada limited
liability company, and Jefferson Street Capital LLC, a New Jersey limited liability company (collectively, the “Investors”).
Pursuant to the SPAs, among other things, the Company agreed to issue to the Investors (i) convertible notes in the original principal
amounts of $182,926.83 and $150,000.00 (the “Notes”), respectively, and (ii)
warrants to purchase up to 318,314 and 217,391 shares of the Company’s common stock, par value $0.001 per share (the “Common
Stock”) (the “Warrants”, and together with the SPAs and the Notes, the “Agreements”),
respectively. Upon closing, the Company received $252,500 in gross proceeds from the Investors.
The Notes mature on May 24, 2023. The Investors
may only convert the Notes at any time on or following (i) the occurrence of an event of default under the Notes or (ii) the date the
Company consummates an offering that results in the listing of the Company’s Common Stock on any national securities exchange on
or before 180 calendar days after the Issue Date (an “Uplist Offering”). The per share conversion price into which
the Note is convertible into shares of Common Stock (the “Conversion Price”) is equal the lower of (i) 75% of the closing
price of the Common Stock on the date of the investment, and (ii) 90% of the lowest volume weighted average price for the Common Stock
during the five trading day period ending on the latest complete trading day prior to the conversion date, provided, however, that if
the Company consummates an Uplist Offering, then the Conversion Price shall equal 75% of the offering price per share of Common Stock
(or unit, if units are offered in the Uplist Offering) at which the Uplist Offering is made.
Upon the occurrence and during the continuation
of any event of default under the Notes, the Notes become immediately due and payable and the Company is obligated to pay the Investors
in full satisfaction of its obligations thereunder an amount equal to the principal amount then outstanding plus accrued interest (including
any default interest) through the date of full repayment multiplied by 150%.
The obligations
under the Notes are not secured by any assets of the Company.
The Warrants provide the Investors with the right
to purchase up to up to 318,314 and 217,391 shares of Common Stock, respectively, at an exercise price of $0.575, provided, however, that
if the Company consummates an Uplist Offering, then the exercise price shall equal 120% of the offering price per share of Common Stock
(or unit, if units are offered in the Uplist Offering) at which the Uplist Offering is made. The right to purchase such shares of Common
Stock under the Warrants is subject to the adjustments and the Investor ownership limitations set forth therein, until the date which
is the last calendar day of the month in which the third anniversary of the Issue Date occurs.
The Notes and the Warrants also provide the Investors
with certain “piggyback” registration rights, permitting them to request that the Company include the shares issued upon conversion
of the Notes or exercise of the Warrants, respectively, for sale in certain registration statements filed by the Company under the Securities
Act of 1933, as amended (the “Securities Act”).
The
Agreements contain other provisions, covenants and restrictions common with this type of debt transaction, including a no shorting provision
preventing the Investor from taking a short position against the Company’s stock. Furthermore, the Company is subject to certain
negative covenants under the Agreements, which the Company also believes are also customary for transactions of this type.
The preceding summaries of the SPAs, the Notes
and the Warrants do not purport to be complete and are qualified in their entirety by reference to the full text of the SPAs, the Notes
and the Warrants, which are filed as Exhibits 10.1 and 10.4, 10.2 and 10.5, and 10.3 and 10.6, respectively, to this Current Report on
Form 8-K and incorporated herein by reference.
The Agreements have been included as exhibits
to this Current Report on Form 8-K to provide investors and securityholders with information regarding certain of its terms. This information
is not intended to provide any financial or other information about the parties to the Agreements or their respective subsidiaries or
affiliates. The representations, warranties and covenants contained in the Agreements are made only for purposes of the Agreements and
as of the date of the Agreements, are solely for the benefit of the parties to the Agreements, may be subject to limitations agreed upon
by the parties, and may be subject to standards of materiality applicable to the parties that differ from those applicable to investors.
Investors should not rely on the representations, warranties and covenants or any description thereof as characterizations of the actual
state of facts or condition of the parties to the Agreements or any of their respective subsidiaries or affiliates. Moreover, information
concerning the subject matter of the representations, warranties and covenants may change after the date of the Agreements, and such subsequent
information may not be fully reflected in public disclosures by the parties to the Agreements. The information in the Agreements should
be considered in conjunction with the entirety of the factual disclosure about the Company in the Company’s public reports filed
with the Securities and Exchange Commission (the “SEC”).